Plant Extracts for Health Benefits and Nutrition

A special issue of Plants (ISSN 2223-7747). This special issue belongs to the section "Phytochemistry".

Deadline for manuscript submissions: 30 September 2025 | Viewed by 1379

Special Issue Editor


E-Mail Website
Guest Editor
Department of Hygiene, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0374, Japan
Interests: medical science; plant extract; human health effect; chronotoxicity

Special Issue Information

Dear Colleagues, 

Plant extracts have gained significant attention for their potential health benefits in recent years. Many people are turning to natural remedies for various conditions, and plant-based extracts are often used in supplements, skincare, and even as part of traditional medicine practices. Although recent research has tended to focus on the pharmacological or toxicological effects of single substances, understanding the effects of crude extracts is an initial step in discovering effective compounds.

In this Special Issue, we invite the submission of full reviews, original research, and short communications related to health benefits and nutrition using in vivo and in vitro experiment. We also welcome not only crude extracts but also compounds identified from plant extracts. However, we do not accept work on the discovery of new compounds from plant extracts without functional evaluation. 

Dr. Hiroki Yoshioka
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Plants is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • phytochemistry
  • medicinal plants
  • bioactive compounds
  • plant-derived drugs
  • cancer
  • heart disease
  • diabetes
  • obesity
  • liver disease
  • kidney disease
  • cerebrovascular disease
  • skin disease

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

14 pages, 2493 KiB  
Article
Sasa veitchii Extract Mitigates Mycophenolate Mofetil-Induced Human Palatal Cell Proliferation Inhibition by Downregulating microRNA-4680-3p
by Hanane Horita, Yosuke Tsukiboshi, Kenichi Ogata, Aya Ogata, Hisaka Kurita, Shuji Yamashita, Hirotaka Yamashita, Naoki Inagaki, Hyogo Horiguchi and Hiroki Yoshioka
Plants 2025, 14(7), 1150; https://doi.org/10.3390/plants14071150 - 7 Apr 2025
Viewed by 465
Abstract
Cleft palate is a common birth defect worldwide and is caused by both genetic and environmental factors. Intrauterine drug exposure is one of the environmental factors that can induce cleft palate. Mycophenolate mofetil (MPM) is an immunosuppressant drug with teratogenic effects, including cleft [...] Read more.
Cleft palate is a common birth defect worldwide and is caused by both genetic and environmental factors. Intrauterine drug exposure is one of the environmental factors that can induce cleft palate. Mycophenolate mofetil (MPM) is an immunosuppressant drug with teratogenic effects, including cleft palate. However, the research on MPM-induced cleft palate remains limited. Sasa veitchii extract (SE), a medical plant extract, is commercially available in Asia and has been reported to show effectiveness against oral diseases. The purpose of the present study is to evaluate whether SE protects against MPM-induced immunosuppression in human embryonic palatal mesenchymal (HEPM) cells. Cell viability and G1 phase-related cell cycle markers were assessed by co-treatment with MPM and SE. Furthermore, we quantified cleft palate-associated miRNA levels and the expression of its downstream genes. MPM treatment reduced cell viability in a concentration-dependent manner. Co-treatment with SE alleviated MPM-induced inhibition of HEPM cell proliferation. Additionally, SE reduced MPM-induced miR-4680-3p upregulation and the downregulation of its downstream genes (ERBB2 and JADE1). These results suggest that SE alleviated MPM-induced cell proliferation inhibition through modulating miR-4680-3p expression. Full article
(This article belongs to the Special Issue Plant Extracts for Health Benefits and Nutrition)
Show Figures

Figure 1

Review

Jump to: Research

32 pages, 1296 KiB  
Review
Biological Effects of Rosaceae Species in Skin Disorders—An Up-To-Date Overview
by Andreea Maria Cristea, Andreea Smeu, Ioan-Alexandru Cîmpeanu, Andrada Iftode, Sergio Liga, Diana-Simona Tchiakpe-Antal, Daliborca Vlad, Cristina Adriana Dehelean and Dan Iliescu
Plants 2025, 14(11), 1605; https://doi.org/10.3390/plants14111605 - 24 May 2025
Viewed by 352
Abstract
The Rosaceae family, comprising over 3000 species, has been extensively investigated for its therapeutic potential, particularly in dermatological applications. Skin illnesses have become in recent years a serious burden worldwide, with more than 3 billion individuals of all ages affected by a skin [...] Read more.
The Rosaceae family, comprising over 3000 species, has been extensively investigated for its therapeutic potential, particularly in dermatological applications. Skin illnesses have become in recent years a serious burden worldwide, with more than 3 billion individuals of all ages affected by a skin condition. This review focuses on approximately 50 species from genera such as Rosa, Rubus, Prunus, Potentilla, and especially Eriobotrya japonica, which have shown promising biological effects due to their diverse bioactive compounds. This review provides a current perspective on the recent scientific literature that highlights the role of Rosaceae members in managing various skin disorders. Key dermatological conditions addressed include dermatitis, acne, skin aging, melanoma, and psoriasis. By summarizing both in vitro and in vivo findings, this review underscores the importance of Rosaceae species in the development of plant-based dermatological therapies and encourages further research into their mechanisms of action and clinical potential. Full article
(This article belongs to the Special Issue Plant Extracts for Health Benefits and Nutrition)
Show Figures

Figure 1

Back to TopTop